Rayfel W. Schneider
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Cytokine Storm Syndrome Associated with Systemic Juvenile Idiopathic Arthritis.
Journal: Advances in experimental medicine and biology
Published: August 08, 2024
Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses.
Journal: The journal of allergy and clinical immunology. In practice
Published: March 06, 2024
Lengthening sleep reduces pain in childhood arthritis: a crossover randomised controlled trial.
Journal: RMD open
Published: May 30, 2023
A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry.
Journal: Rheumatology (Oxford, England)
Published: May 05, 2023
Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis - Two Ends of the Same Spectrum.
Journal: Frontiers in pediatrics
Published: February 09, 2021
Clinical and psychosocial stress factors are associated with decline in physical activity over time in children with juvenile idiopathic arthritis.
Journal: Pediatric rheumatology online journal
Published: January 30, 2021
Soluble Low-density Lipoprotein Receptor-related Protein 1 in Juvenile Idiopathic Arthritis.
Journal: The Journal of rheumatology
Published: October 02, 2020
Higher concentrations of vitamin D in Canadian children with juvenile idiopathic arthritis compared to healthy controls are associated with more frequent use of vitamin D supplements and season of birth.
Journal: Nutrition research (New York, N.Y.)
Published: October 02, 2020
"It's Not Just About Getting Along": Exploring Learning Through the Discourse and Practice of Interprofessional Collaboration.
Journal: Academic medicine : journal of the Association of American Medical Colleges
Published: August 10, 2020
Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 27, 2020
New Medications Are Needed for Children With Juvenile Idiopathic Arthritis.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 24, 2020
Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 29, 2019
Last Updated: 09/26/2026